Evaluation of Liposome-Encapsulated Vancomycin Against Methicillin-Resistant <i>Staphylococcus aureus</i>

Evaluation of Liposome-Encapsulated Vancomycin Against Methicillin-Resistant <i>Staphylococcus aureus</i>

<b>Background/Objectives:</b> Methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) is a global health concern due to its resistance to conventional antibiotics. This study evaluated the efficacy of liposome-encapsulated vancomycin against MRSA using phospholipids extract...

Full description

Saved in:

Bibliographic Details
Main Authors:	Enkhtaivan Erdene, Odonchimeg Munkhjargal, Galindev Batnasan, Enkhjargal Dorjbal, Baatarkhuu Oidov, Ariunsanaa Byambaa
Format:	Article
Language:	English
Published:	MDPI AG 2025-02-01
Series:	Biomedicines
Subjects:	liposome vancomycin MRSA nanocarriers wound healing
Online Access:	https://www.mdpi.com/2227-9059/13/2/378
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Determination of Antimicrobial Activity of Antibiotics Encapsulated in Liposomes
by: Enkhtaivan Erdene, et al.
Published: (2024-03-01)

Formulation and Characterization of Bone-Targeting Vancomycin-Loaded Liposomes
by: Basel Karzoun, et al.
Published: (2025-06-01)

Dual Antibiotic-Infused Liposomes to Control Methicillin-Resistant <i>Staphylococcus aureus</i>
by: Sourav Chakraborty, et al.
Published: (2025-05-01)

Vancomycin susceptibility trends of methicillin-resistant Staphylococcus aureus isolated from burn wounds: a time for action
by: Abdulaziz Abdulhafid Zorgani, et al.
Published: (2015-11-01)

Cell Wall Biosynthesis Genes Variability in Methicillin-Resistant Staphylococcus Aureus with Reduced Vancomycin Susceptibility
by: V. V. Gostev, et al.
Published: (2020-05-01)

The Prevalence of Methicillin Resistant Staphylococcus Aureus (MRSA) and its Antimicrobial Susceptibility Pattern at Tertiary Care Hospital
by: Nisarg Trivedi, et al.
Published: (2025-02-01)

Sodium Alginate Microneedles Loaded with Vancomycin for Skin Infections
by: Juhaina M. Abu Ershaid, et al.
Published: (2024-10-01)

Results of Investigation of MRSA Susceptibility to Vancomycin in Clinical Units of Large Multifunctional Hospital and Recommendations on Optimization of Antibacterial Therapy of Staphylococcal Infection
by: V. A. Verikovsky, et al.
Published: (2020-05-01)

Methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility in Taiwan
by: Chien-Yu Lin, et al.
Published: (2018-01-01)

Estimation of MRSA Susceptibility to Oxacillin, Cefoxitine, Vancomycin and Daptomyci
by: V. V. Gostev, et al.
Published: (2020-05-01)

Synergistic effect between vancomycin and traditional Chinese medicine (TCM) herbs against methicillin-resistant Staphylococcus aureus (MRSA) infections
by: Prateek Porwal, et al.
Published: (2024-12-01)

Methicillin and vancomycin-resistant Staphylococcus aureus and associated risk factors among patients with wound infection in East Wallaga Zone, Western Ethiopia
by: Milkias Abebe, et al.
Published: (2024-12-01)

Transformative Impact of Nanocarrier‐Mediated Drug Delivery: Overcoming Biological Barriers and Expanding Therapeutic Horizons
by: Minhye Kim, et al.
Published: (2024-11-01)

Characterization, genomic analysis and preclinical evaluation of the lytic Staphylococcus bacteriophage PSK against methicillin-resistant Staphylococcus aureus wound isolate
by: Abanoub A. Zanaty, et al.
Published: (2025-02-01)

Incidence of methicillin, inducible clindamycin, and vancomycin resistance in Staphylococcus aureus clinical isolates in Gombe, Northeastern Nigeria
by: Haruna Adamu, et al.
Published: (2025-03-01)

Advances in Liposomal Drug Delivery: Multidirectional Perspectives on Overcoming Biological Barriers
by: Żaneta Sobol, et al.
Published: (2025-07-01)

Transgenic zebrafish embryos to evaluate the in vivo effects of different liposome-paclitaxel nanocarrier system
by: Andrea Persico, et al.
Published: (2025-05-01)

Synergism Effects of Vancomycin and Zinc Oxide Nanoparticles on Methicillin Resistance Staphylococcus aureus (MRSA) and Lung Cancer
by: Mohammad Shokrzadeh Lamuki, et al.
Published: (2023-11-01)

A TAT Peptide-Functionalized Liposome Delivery Phage System (TAT-Lip@PHM) for an Enhanced Eradication of Intracellular MRSA
by: Kaixin Liu, et al.
Published: (2025-06-01)

Molecular and phenotypic characteristics of methicillin-resistant Staphylococcus aureus isolated from hospitalized patients
by: Caio Ferreira de Oliveira, et al.
Published: (2015-07-01)

Oligo(ethylene glycol) Methacrylate Copolymer-Modified Liposomes for Temperature-Responsive Drug Delivery System
by: Maria Isabel Martinez Espinoza, et al.
Published: (2024-11-01)

Genomic and phenotypic adaptations of methicillin resistant Staphylococcus aureus during vancomycin therapy
by: Yiyue Jiang, et al.
Published: (2025-05-01)

Activity of contezolid against methicillin-resistant Staphylococcus aureus in a rat model of foreign body osteomyelitis
by: Sebastian C. Herren, et al.
Published: (2025-06-01)

Controlled Functionalization Strategy of Proteins Preserves their Structural Integrity While Binding to Nanocarriers
by: Ana Mateos‐Maroto, et al.
Published: (2024-10-01)

Effect of chitosan nanogels loaded with vancomycin and gamma interferon on TNF-α gene expression in macrophage cell line activated with methicillin-resistant Staphylococcus aureus (MRSA)
by: Sahar Arkiya, et al.
Published: (2024-10-01)

Unveiling the synergistic power of 3-hydrazinoquinoxaline-2-thiol and vancomycin against MRSA: An in vitro and in silico evaluation
by: Ohood S Alharbi, et al.
Published: (2025-04-01)

Optimizing glycerosome formulations via an orthogonal experimental design to enhance transdermal triptolide delivery
by: Zhu Chunyun, et al.
Published: (2022-03-01)

Azithromycin-loaded liposomal hydrogel: a step forward for enhanced treatment of MRSA-related skin infections
by: Rukavina Zora, et al.
Published: (2023-12-01)

Oral vancomycin use and incidence of vancomycin-resistant enterococci: time-series analysis
by: Seongman Bae, et al.
Published: (2024-12-01)

Methicillin resistance Staphylococcus aureus (MRSA) and Vancomycin Resistant Staphylococcus aureus (VRSA) problem in human and livestock and solutions.
by: Marwan Mohammed, et al.
Published: (2023-12-01)

Pharmacokinetic effect of disease severity and use of extracorporeal membrane oxygenation in critically ill Asian patients receiving vancomycin
by: Charul Avachat, et al.
Published: (2025-02-01)

Surface-functionalized UIO-66-NH2 for dual-drug delivery of vancomycin and amikacin against vancomycin-resistant Staphylococcus aureus
by: Nazanin Rahmanian, et al.
Published: (2024-11-01)

Nanoscale Therapeutic System: Safety Assessment Features
by: E. M. Bovina, et al.
Published: (2019-09-01)

Vancomycin-Resistant <i>E. faecium</i>: Addressing Global and Clinical Challenges
by: Daniel E. Radford-Smith, et al.
Published: (2025-05-01)

Evaluation of vancomycin individualized model-based dosing approach in neonates
by: Manal Abouelkheir, et al.
Published: (2023-05-01)

Impact of tranexamic acid on the efficacy of vancomycin and meropenem against periprosthetic joint infections: an in vitro analysis
by: Liqin Yao, et al.
Published: (2025-07-01)

Uncovering the silent public health threat: nasal carriers of linezolid-resistant, vancomycin-intermediate and mupirocin-resistant MRSA among healthcare workers in a tertiary care hospital in Central India
by: Bawankar, Neha S., et al.
Published: (2025-05-01)

Is there an association between colonisation of vancomycin resistant Enterococci, methicillin resistant Staphylococcus Aureus, or Clostridiodes Difficile and mortality in sepsis?
by: Matthew JG. Sigakis, et al.
Published: (2024-12-01)

Vancomycin Therapeutic Drug Monitoring
by: Bhaskar Shenoy, et al.
Published: (2023-04-01)

Clinical characteristics and early identification of augmented renal clearance in PICU patients with severe sepsis associated with MRSA infection
by: Haonan Wang, et al.
Published: (2024-11-01)